Cardiac arrhythmias of BCR-ABL inhibitors with or without triazole antifungal agents: A real-world pharmacovigilance study based on the food and drug administration adverse event reporting system database
BCR-ABL inhibitors plus triazole antifungal agents increase the risk of cardiac arrhythmia, particularly in the early stages of treatment, with the risk decreasing over time.
Authors
- Lishan Lu
- Rongrong Jia (ORCID: https://orcid.org/0000-0001-6868-9594)
- Yixuan Tian
- Xuemei Tian (ORCID: https://orcid.org/0000-0001-7920-3801)
- Pu Bai
- Peng Xie (ORCID: https://orcid.org/0000-0001-7499-1669)
Institutions
- Inner Mongolia University of Science and Technology (CN)
- Baotou Medical College (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- SAGE Open Medicine
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1177/20503121251328762
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00